Login

Forgot Password?

New user?  Sign up here

OR

Sign in with Google

Register

Continue with Google

OR

Sample Message..!

Already Registered?

Complete Your Profile

Change Password

Request a Password Reset

Enter your email below and we will send you instructions to reset your password.

Sample Message..!

Download Documents

 Tender Notice

Download

Home » Search RFP » Latest Global Dosage Kit RFP & RFQ

Latest Global Dosage Kit RFP & RFQ

TendersOnTime provides latest Dosage Kit RFP, Dosage Kit RFQ, Dosage Kit RFI from various sectors & countries. The information on Dosage Kit Request For Proposal, Dosage Kit Request For Quotation and other federal business opportunities is aggregated from newspapers, e tender portal, etender websites and tender bulletin. Federal Contractors can register Free, to get the latest info from the database of Global Dosage Kit RFP.

Dynamic purchasing system: Medical aids

Deadline: 12 Apr 2029

Norway

Deadline: 12 Apr 2029

TOT Reference No.: 32354975

View Details

Medicines with the Active Ingredient Infliximab - in the Dosage Form Powder (Atc:L04ab02)

Deadline: 31 Aug 2025

Germany

Deadline: 31 Aug 2025

TOT Reference No.: 89376345

View Details

Drugs with the Active Ingredient Diclofenac (Atc Code: D11ax18 - Topical Dosage Forms Only)

Deadline: 31 Mar 2025

Germany

Deadline: 31 Mar 2025

TOT Reference No.: 81884309

View Details

Oh-Biologika-2023-12 - Insulin, Normal (Human) (Dosage Form: Cylinder Ampoules)

Deadline: 31 Jul 2025

Germany

Deadline: 31 Jul 2025

TOT Reference No.: 82925798

View Details

Oh-Biologika-2023-13 - Insulin Isophane (Human) (Dosage Form: Cylinder Ampoules)

Deadline: 31 Jul 2025

Germany

Deadline: 31 Jul 2025

TOT Reference No.: 82932699

View Details

Medicines with the Active Ingredient Infliximab - in the Dosage Form Injection Solution (Atc

Deadline: 31 Aug 2025

Germany

Deadline: 31 Aug 2025

TOT Reference No.: 89387595

View Details

Medicines with the Active Ingredient Testosterone (Atc: G03ba03 - in the Dosage Form Injection

Deadline: 30 Apr 2026

Germany

Deadline: 30 Apr 2026

TOT Reference No.: 101543470

View Details

Open House Biologics Rebate Agreements 2022-23 - Natalizumab (Dosage Form for Intravenous Use)

Deadline: 31 Jan 2025

Germany

Deadline: 31 Jan 2025

TOT Reference No.: 76696719

View Details

Medicinal Products with the Active Ingredient Octreotide (Atc: H01cb02 - Prolonged-Release Dosage

Deadline: 28 Feb 2025

Germany

Deadline: 28 Feb 2025

TOT Reference No.: 80720731

View Details

Dosage Forms)

Deadline: 28 Feb 2025

Germany

Deadline: 28 Feb 2025

TOT Reference No.: 80721006

View Details

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

{{rowDetails.Country_Name}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

TOT Reference No.: {{rowDetails.ID}}

View Details

No Data Found..!!

AFRICA TENDERS

AMERICAS TENDERS
Show More
Show More
Show More
Show More
Show More

Browse Tenders

Browse Tenders from below Sections

Regions

Countries

geo-political

funding agencies

Sectors

Indian states

Indian cities

purchasers
Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.